Adar Poonawalla helps Indian Students studying abroad

The CEO of Serum group of Institutes, Adar Poonawalla has said on Thursday that he has set aside 10 crore rupees for students studying abroad. Covishield, made by Serum group of Institutes, is not yet accepted by many nations.

On Thursday, he said that not many nations have approved Cov...

SII CEO POONAWALLA THANKS US PRESIDENT BIDEN, INDIAN EAM JAISHANKAR FOR POLICY CHANGE ON VACCINE

Highlights

• In a response to Poonawalla’s tweet, the India’s EAM said that the “Indian diplomacy is focussed on securing the vaccine supply chain.”

Responding to the decision made by the United States to remove Defense Production Act priority rati...

SERUM IN TALKS WITH US GOVERNMENT REGARDING RAW MATERIAL REQUIRED FOR COVOVAX

Highlights

• Last month the SII CEO Adar Poonawalla had urged the President of the US, Joe Biden to lift the embargo

According to the sources, the Serum Institute of India (SII) has approached the United States government in order to clarify that it needs the supply of ra...

SII CEO ADAR POONAWALLA URGES U.S. PRESIDENT BIDEN TO LIFT EMBARGO ON COVID-19 VACCINE RAW MATERIALS

Highlights

• The Serum Institute of India CEO Adar Poonawalla on Friday urged the President of the US, Joe Biden to lift the embargo on COVID-19 vaccine raw materials

• The Serum Institute CEO had recently said that he understands the increasing demand for retaining ...

US, EUROPE BAN EXPORT OF CRITICAL RAW MATERIALS REQUIRED TO MAKE COVID VACCINES: SII CEO POONAWALLA

Highlights

• The United States along with the European nations have imposed a ban on export of critical raw materials needed to manufacture the vaccine for dreadful coronavirus

• The Serum Institute CEO said that he understands the increasing demand for retaining all...

SERUM INSTITUTE CEO WARNS OF COVID-19 VACCINE SHORTAGE TILL 2024

HIGHLIGHTS

• Serum Institute CEO says that till 2024, coronavirus vaccine availability will not be enough.
• Two doses of vaccine are required to create immunity against coronavirus.

On Monday, 14 SEP 2020, Adar Poonawalla, the CEO of Se...

NOVAVAX, SERUM INSTITUTE OF INDIA JOIN HANDS TO SUPPLY COVID-19 VACCINE

Highlights

• The Serum Institute of India will have exclusive rights for the COVID-19 vaccine in India and non-exclusive rights during the pandemic period in all countries except those designated as upper-middle or high-income nations

• The COVID-19 vaccine developed...

PUNE-BASED MYLAB GETS COMMERCIAL APPROVAL FROM ICMR FOR ANTIGEN KITS

Highlights

• The antigen kit developed by Mylab Discovery Solutions will cost Rs 450 per unit

• Serum Institute of India, CEO Adar Poonawalla has invested over Rs 100 crore and owns less than 50 percent stake in Mylab

• This antigen kit was co-develope...